What is the official website of Expert Perspectives by Engage Health Media ?

The official website of Expert Perspectives by Engage Health Media is http://expertperspectives.com/endocrinology/diabetes-mellitus/.

What is Expert Perspectives by Engage Health Media's cybersecurity risk score?

Expert Perspectives by Engage Health Media has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Expert Perspectives by Engage Health Media experienced?

According to Rankiteo, Expert Perspectives by Engage Health Media currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Expert Perspectives by Engage Health Media been affected by any supply chain cyber incidents ?

According to Rankiteo, Expert Perspectives by Engage Health Media has been affected by a supply chain cyber incident involving Snowflake, with the incident ID ATT1764820523.

Does Expert Perspectives by Engage Health Media have SOC 2 Type 1 certification ?

According to Rankiteo, Expert Perspectives by Engage Health Media is not certified under SOC 2 Type 1.

Does Expert Perspectives by Engage Health Media have SOC 2 Type 2 certification ?

According to Rankiteo, Expert Perspectives by Engage Health Media does not hold a SOC 2 Type 2 certification.

Does Expert Perspectives by Engage Health Media comply with GDPR ?

According to Rankiteo, Expert Perspectives by Engage Health Media is not listed as GDPR compliant.

Does Expert Perspectives by Engage Health Media have PCI DSS certification ?

According to Rankiteo, Expert Perspectives by Engage Health Media does not currently maintain PCI DSS compliance.

Does Expert Perspectives by Engage Health Media comply with HIPAA ?

According to Rankiteo, Expert Perspectives by Engage Health Media is not compliant with HIPAA regulations.

Does Expert Perspectives by Engage Health Media have ISO 27001 certification ?

According to Rankiteo,Expert Perspectives by Engage Health Media is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Expert Perspectives by Engage Health Media operate in ?

Expert Perspectives by Engage Health Media operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Expert Perspectives by Engage Health Media have ?

Expert Perspectives by Engage Health Media employs approximately 0 people worldwide.

Does Expert Perspectives by Engage Health Media own any subsidiaries ?

Expert Perspectives by Engage Health Media presently has no subsidiaries across any sectors.

How many LinkedIn followers does Expert Perspectives by Engage Health Media have ?

Expert Perspectives by Engage Health Media's official LinkedIn profile has approximately 40 followers.

What is the NAICS classification code for Expert Perspectives by Engage Health Media ?

Expert Perspectives by Engage Health Media is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Expert Perspectives by Engage Health Media have a Crunchbase profile ?

No, Expert Perspectives by Engage Health Media does not have a profile on Crunchbase.

Does Expert Perspectives by Engage Health Media have a LinkedIn profile ?

Yes, Expert Perspectives by Engage Health Media maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/expert-perspectives.

How many cybersecurity incidents has Expert Perspectives by Engage Health Media experienced ?

As of June 8, 2026, Rankiteo reports that Expert Perspectives by Engage Health Media has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Expert Perspectives by Engage Health Media have ?

Expert Perspectives by Engage Health Media has an estimated 5,674 peer or competitor companies worldwide.

What types of cybersecurity incidents has Expert Perspectives by Engage Health Media faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

EPEHM

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Expert Perspectives by Engage Health Media Vendor Cyber Rating & Cyber Score

expertperspectives.com

Add Your Compliance Badge

A customized publication featuring highly prominent thought leaders providing their expert opinions, insights, and commentary on the leading topics and issues in specific disease state medicine.

EPEHM A.I CyberSecurity Scoring

Scoring History

EPEHM

Expert Perspectives by Engage Health Media CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Omnicom

Breach

1/2024

Snowflake

ATT1764820523

Loading…

A.I.

EPEHM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for EPEHM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Expert Perspectives by Engage Health Media in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Expert Perspectives by Engage Health Media in 2026.

Incident Types EPEHM vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Expert Perspectives by Engage Health Media in 2026.

Incident History - EPEHM (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Expert Perspectives by Engage Health Media Subsidiaries

EPEHM

Pharmaceutical Manufacturing

Website: http://expertperspectives.com/endocrinology/diabetes-mellitus/

Company Size: 0

OmnicomAdvertising Services

DDB Mudra GroupAdvertising Services

Wolff OlinsDesign Services

AlmapBBDOAdvertising Services

Zimmerman AdvertisingAdvertising Services

IMPACT BBDOAdvertising Services

AMV BBDOAdvertising Services

TMA (The Marketing Arm)Advertising Services

FanscapeAdvertising Services

Omnicom Media Group Asia PacificAdvertising Services

sparks & honeyBusiness Consulting and Services

Patients & PurposeAdvertising Services

cdmAdvertising Services

Javelin AgencyAdvertising Services

Omnicom Media Group SpainAdvertising Services

BBDO & Proximity EspañaAdvertising Services

Somos #WEObservatorioAdvertising Services

HaygarthAdvertising Services

Doremus+CoAdvertising Services

B2BSideAdvertising Services

OmnicomMediaGroup USAAdvertising Services

Rabin MartinBusiness Consulting and Services

Private Sector Roundtable on Global Health Security (PSRT)International Affairs

BBDO GuerreroAdvertising Services

Beanstalk - Brand Extension Licensing AgencyMarketing Services

Tinderbox - Digital Brand LicensingAdvertising Services

Beanstalk América LatinaServicios de publicidad

Entrée HealthAdvertising Services

Omnicom PR GroupPublic Relations and Communications Services

Adelphi ValuesPharmaceutical Manufacturing

Proximity WorldwideAdvertising Services

KERNAdvertising Services

Resolution DigitalAdvertising Services

BBDO EcuadorAdvertising Services

Graviti BBDOAdvertising Services

SSCG Media GroupAdvertising Services

BBDO NordicsAdvertising Services

ConePublic Relations and Communications Services

NOVUS Media LLCAdvertising Services

H&S CommunicationsPublic Relations and Communications Services

OMD ArgentinaAdvertising Services

Serino CoyneAdvertising Services

Archbow ConsultingPharmaceutical Manufacturing

Ketchum BrazilPublic Relations and Communications Services

AlconeAdvertising Services

MTS | Marketing Technology SolutionsAdvertising Services

PHD, Inc.Industrial Automation

PHD, Inc. | Europe Herstellung von Automatisierungsanlagen

PHD, Inc. | China工业自动化

InteroneAdvertising Services

ColangeloAdvertising Services

The Scienomics GroupAdvertising Services

Omnicom CommerceAdvertising Services

Proximedia BelgiumInternet Publishing

Casers GroupAdvertising Services

Omnicom Media Group, CzechAdvertising Services

OMG (Omni Marketing Global)Advertising Services

ActMedia (OMG)Advertising Services

DemoPower (OMG)Advertising Services

CPC (OMG)Advertising Services

Graffiti BBDOAdvertising Services

Fishburn HedgesPublic Relations and Communications Services

Omnicom PR Group NLPublic Relations and Communications Services

Brandzeichen Markenberatung und Kommunikation GmbHPublic Relations and Communications Services

Child and Youth Care Association of AlbertaCivic and Social Organizations

Davie Brown EntertainmentEntertainment Providers

U30 GroupMarket Research

DDB Frankfurt GmbHAdvertising Services

Omnicom Health Group: Snow CompaniesAdvertising Services

OMD Optimum Media UkraineAdvertising Services

BBDO Proximity DuesseldorfAdvertising Services

BAREFOOTAdvertising Services

TRANSACT NorwayAdvertising Services

Tribal Worldwide AthensAdvertising Services

Sterling International Consulting GroupIT Services and IT Consulting

OPERA / Omnicom Media GroupAdvertising Services

K Comms GmbH (Swiss Partner of KetchumPleon)Public Relations and Communications Services

Omnicom Media Group FranceAdvertising Services

TPNAdvertising Services

The Zimmerman AgencyMarketing Services

BBDO San FranciscoAdvertising Services

Agency 720Advertising Services

BioPharm CommunicationsAdvertising Services

Loading…

Expert Perspectives by Engage Health Media Similar Companies

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Servier

servier.com

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, and Eastern Europe. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide. -- To report a suspected adverse event with a Servier drug, please visit servier.com

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Loading…

NEWS

Expert Perspectives by Engage Health Media CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Expert Perspectives on 10-Year Moratorium on Enforcement of US State AI Laws

It establishes liability for use of AI that violates consumer protection laws if not properly disclosed and requires disclosure when an ...

Read Article

What the HIPAA rulemaking notice means for you

The notice of proposed rulemaking from HHS in December 2024 that was designed to strengthen cybersecurity requirements.

Read Article

Prioritising eHealth cybersecurity against emerging challenges

The rising digitalisation and interconnectedness in healthcare has significantly increased the sector's exposure to cyber threats and raised ...

Read Article

Medical Channel Asia (MCA) Reports 5 Million Health Content Views in Q1, Reveals Audience’s Top Health Trends

Medical Channel Asia's Q1 2025 data highlights the scale of public demand for trusted health information, with close to 200,000 page views on ...

Read Article

Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy

ChatGPT can help people be more creative and productive and improve organisational knowledge management. But it amplifies many AI challenges that organisations ...

Read Article

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

In 2025 the new normal will imply a society more sharply divided between those who have access and those who don't. Fernando Barrio, a lecturer ...

Read Article

Countering Disinformation Effectively: An Evidence-Based Policy Guide

A high-level, evidence-informed guide to some of the major proposals for how democratic governments, platforms, and others can counter ...

Read Article

How wellness-as-a-service can drive growth for life and health insurers

Discover how wellness-as-a-service can drive growth for life and health insurers by integrating physical & financial health and leveraging ...

Read Article

3. Themes: The most harmful or menacing changes in digital life that are likely by 2035

“Harmful or menacing changes in digital technology and humans' use of digital systems happen because we have not sufficiently prepared ourselves ...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-11466

SUMMARY

A weakness has been identified in zilliztech deep-searcher up to 0.0.2. This affects the function CollectionRouter.invoke of the file deepsearcher/agent/collection_router.py. This manipulation of the argument kwargs causes improper access controls. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be used for attacks. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 5.4)

cvss2

Base Score: 5.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:P

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-11465

SUMMARY

A security flaw has been discovered in songquanpeng one-api up to 0.6.11-preview.7. Affected by this issue is the function Redeem of the file model/redemption.go of the component Redemption Code Top-Up Endpoint. The manipulation results in business logic errors. The attack may be launched remotely. The attack requires a high level of complexity. The exploitation is known to be difficult. The exploit has been released to the public and may be used for attacks. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:N/I:L/A:N

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-11464

SUMMARY

A vulnerability was identified in JeecgBoot up to 3.9.2. Affected by this vulnerability is the function queryPageList of the file src\main\java\org\jeecg\modules\system\controller\SysUserController.java of the component User List Endpoint. The manipulation of the argument salt leads to information disclosure. The attack may be initiated remotely. The attack is considered to have high complexity. The exploitation appears to be difficult. The exploit is publicly available and might be used. A fix is planned for the upcoming release.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:P/I:N/A:N

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-11463

SUMMARY

A vulnerability was determined in USCiLab Cereal up to 1.3.2. Affected is an unknown function of the component Shared Pointer Handler. Executing a manipulation can lead to type confusion. The attack can be launched remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-11462

SUMMARY

A vulnerability was found in Chengdu Everbrite Network Technology BeikeShop up to 1.6.0.22. This impacts the function callback of the file plugins/Stripe/Controllers/StripeController.php of the component Stripe Plugin. Performing a manipulation of the argument Request results in improper authorization. The attack can be initiated remotely. The exploit has been made public and could be used. The patch is named 6719e0fc690ea0a998452092862e0f0a17c65968. It is suggested to install a patch to address this issue.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Expert Perspectives by Engage Health Media Vendor Cyber Rating & Cyber Score

EPEHM A.I CyberSecurity Scoring

Expert Perspectives by Engage Health Media CyberSecurity News & History

EPEHM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for EPEHM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types EPEHM vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - EPEHM (X = Date, Y = Severity)

Expert Perspectives by Engage Health Media Subsidiaries

EPEHM

Expert Perspectives by Engage Health Media Similar Companies

MANKIND PHARMA LTD

Servier

AUROBINDO PHARMA LTD

AbbVie

Sandoz

Johnson & Johnson Innovative Medicine

PT Kalbe Farma, Tbk

Bristol Myers Squibb

Sanofi

Expert Perspectives by Engage Health Media CyberSecurity News

Expert Perspectives on 10-Year Moratorium on Enforcement of US State AI Laws

What the HIPAA rulemaking notice means for you

Prioritising eHealth cybersecurity against emerging challenges

Medical Channel Asia (MCA) Reports 5 Million Health Content Views in Q1, Reveals Audience’s Top Health Trends

Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

Countering Disinformation Effectively: An Evidence-Based Policy Guide

How wellness-​as-a-service can drive growth for life and health insurers

3. Themes: The most harmful or menacing changes in digital life that are likely by 2035

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Expert Perspectives by Engage Health Media CyberSecurity News & History

EPEHM Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for EPEHM

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types EPEHM vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - EPEHM (X = Date, Y = Severity)

Expert Perspectives by Engage Health Media Subsidiaries

EPEHM

Expert Perspectives by Engage Health Media Similar Companies

MANKIND PHARMA LTD

Servier

AUROBINDO PHARMA LTD

AbbVie

Sandoz

Johnson & Johnson Innovative Medicine

PT Kalbe Farma, Tbk

Bristol Myers Squibb

Sanofi

Expert Perspectives by Engage Health Media CyberSecurity News

Expert Perspectives on 10-Year Moratorium on Enforcement of US State AI Laws

What the HIPAA rulemaking notice means for you

Prioritising eHealth cybersecurity against emerging challenges

Medical Channel Asia (MCA) Reports 5 Million Health Content Views in Q1, Reveals Audience’s Top Health Trends

Opinion Paper: “So what if ChatGPT wrote it?” Multidisciplinary perspectives on opportunities, challenges and implications of generative conversational AI for research, practice and policy

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

Countering Disinformation Effectively: An Evidence-Based Policy Guide

How wellness-​as-a-service can drive growth for life and health insurers

3. Themes: The most harmful or menacing changes in digital life that are likely by 2035

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

How wellness-as-a-service can drive growth for life and health insurers

How wellness-as-a-service can drive growth for life and health insurers